For Institutional Investors in the US
We believe in the sharing of expert insight for better investment and business decisions. We call this ethos
Access to Medicine: The Need for Innovation, Partnerships and Data Capture
How pharmaceutical companies are addressing the issue of inequitable access to medicine.
Subscribe for relevant insights delivered straight to your inbox
Dissecting the reflation narrative as we head into the spring/summer inflation surge and vaccine-driven reopenings of 2021.
The complexities of the economic recovery have led to an ongoing push-pull in equity markets.
Assessing the benefits of active collaboration in stock and bond analysis.
A look at different approaches to capturing micro and macro trends in markets.
Large-scale trading activity periodically creates short-term dislocations that may present investment opportunities.
Andrew Mulliner explains why 2021 will likely be a year of recovery, though he cautions that investors should keep one eye on inflation and inflation expectations.
While volatility should diminish in 2021, uncertainties remain that investors will need to prepare for.
Though volatility is likely to continue, Portfolio Manager Jeremiah Buckley thinks the outlook for equities remains constructive as we progress past the election and get closer to the end of the coronavirus pandemic.
David Elms, Head of Diversified Alternatives, argues for new thinking for investors’ portfolios in 2021, following a year in which the pandemic posed unfamiliar challenges for industries.
In this Q&A, David Elms, Head of Diversified Alternatives at Janus Henderson Investors, discusses the role of alternatives in uncertain markets.
The options market signals that riskier assets may find a supportive environment in an era of split government and policy moderation.
Always looking out for surprises, options markets are giving President Trump better odds than what are currently reflected in consensus polling data.